Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
π° News Media
- π§ͺ [Colorado] Colorado Marijuana Company Voluntarily Recalls Dozens of Contaminated Products Amid State Regulatory Delays - propublica.org
- π₯ [Oklahoma City, Oklahoma] With 100 days left, OK County shifts ARPA funds to new Behavioral Care Center - oklahoman.com
- πΏ [Oxford, MS] Deaths of students at the University of Mississippi cast spotlight on kratom - baltimoresun.com
- πΏ [Detroit, Michigan] 2 Ole Miss students dead, kratom suspected. Is it legal in Michigan? - freep.com
- π [National] HRSA Awards Nearly $90 Million to Expand Addiction Treatment and Recovery Services in Rural Communities - hrsa.gov
π£οΈ Social Pulse
Lived/Living Experience
- No posts found today.
Innovation
- πͺ We would like to provide an update regarding our harm reduction vending machine. HCPH has distributed the last of our remaining supply of Xylazine test strips and Fentanyl test strips, and at this time, we will not... - @HuronCoHealth on X
- π¨ β οΈPUBLIC SAFETY ADVISORYβ οΈ #DEA warns fentanyl is being mixed w/highly potent substances like cychlorphine, xylazine, nitazenes, & medetomidine--many not approved for human use & are often undetectable. (link)... - @DEAHQ on X
Opposition Views
π City Updates
π Academic Research
- π Appropriate and Acceptable? A Mixed Methods Study of a βSmartβ Harm Reduction Vending Machine in Pennsylvania - Contemporary Drug Problems - 2026-09-25 - doi.org
- π« Opioid overdose risk and resilience among older Black men in Chicago: findings from community-based focus groups - BMC Public Health - 2026-09-25 - doi.org
- π§ System dynamics and related modeling of opioid use and interventions: a scoping review - Harm Reduction Journal - 2026-09-24 - doi.org
βοΈ Law & Policy
- No hits in Law and Policy today.
πΈ Funding
Current
- Deadline Approaching㪠National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- Deadline Approaching㪠National Institutes of Health - Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) - Deadline: Oct 1, 2026
- π οΈ Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA) - Deadline: Nov 2, 2026
- π¬ National Institutes of Health - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) - Deadline: Jun 16, 2028
- π¬ National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- π¬ National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- π¬ National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- π¨ Hearst Foundations - Social Service - Hearst Foundations β Social Service (Year-Round Rolling Applications; No Deadlines) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- π©Ί Hearst Foundations - Health - Hearst Foundations β Year-round rolling grant applications (Health funding area) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- π§ Open Society Foundations - The Open Society Fellowship - Deadline: rolling
- π€ Smart Family Fund - Angel Philanthropy (Send Us a Pitch) β Small Grants, Big Impact - First time grants ranging from $25,000 to $100,000. - Deadline: Open pitch